Enhancement of Cisplatin Cytotoxicity in Combination With Thymoquinone on Oral Cancer HSC-4 Cell Line
Abstract. Cisplatin (CDDP) is frequently used as an adjuvant chemotherapy in oral cancer management and often associated with significant adverse effects. Natural occurring compounds have provided considerable value in cancer chemotherapeutic research. Thymoquinone (TQ), the main constituent of Nig...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Trans Tech Publications Ltd.
2021
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/89821/1/89821_Enhancement%20of%20Cisplatin%20Cytotoxicity%20in%20Combination%20With%20Thymoquinone.pdf http://irep.iium.edu.my/89821/ https://www.scientific.net/MSF.1025.236 https://doi.org/10.4028/www.scientific.net/MSF.1025.236 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|